
Carbamazepine, HLA-B*1502 and risk of Stevens–Johnson syndrome and toxic epidermal necrolysis: US FDA recommendations
Author(s) -
P. Brent Ferrell,
Howard L. McLeod
Publication year - 2008
Publication title -
carolina digital repository (university of north carolina at chapel hill)
Language(s) - English
DOI - 10.17615/mmm9-xn28
Subject(s) - toxic epidermal necrolysis , carbamazepine , medicine , dermatology , psychiatry , epilepsy